FDA Approved: FLUOXETINE — Supplemental Application (NIVAGEN PHARMACEUTICALS, INC.)

View source ↗

Summary

FDA approves a supplemental application for fluoxetine hydrochloride from NIVAGEN Pharmaceuticals, enabling the marketing of a generic fluoxetine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bulimia Nervosa
• Major Depressive Disorder
• Obsessive-compulsive Disorder
• Panic Disorder
• Premenstrual Dysphoric Disorder

Drugs mentioned

• Fluoxetine hydrochloride (Fluoxetine hydrochloride)

Snippet

SUPPL AP for FLUOXETINE (FLUOXETINE HYDROCHLORIDE)